Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 465 entries
View as:

A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00604123 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00073203 Org: User:
Start: - End: 05/31/04 Due: 05/31/05

Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT00086684 Org: User:
Start: 09/30/03 End: 06/30/11 Due: 06/30/12

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT00229073 Org: User:
Start: 12/31/04 End: 10/31/06 Due: 10/31/07

A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00270179 Org: User:
Start: - End: 05/31/88 Due: 05/31/89

Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis

Phase: N/A Priority: Normal
NCT ID: NCT00229021 Org: User:
Start: 12/31/03 End: 03/31/06 Due: 03/31/07

Early and Standard Intervention With 120,000 Units of PROCRIT (Epoetin Alfa) Every Three Weeks in Patients Receiving Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00210600 Org: User:
Start: 05/31/05 End: 08/31/06 Due: 08/31/07

PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00388336 Org: User:
Start: 02/29/04 End: 03/31/05 Due: 03/31/06

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00231647 Org: User:
Start: 02/29/04 End: 10/31/04 Due: 10/31/05

A Pharmacokinetic Study to Characterize JNJ-39393406 in the Cerebrospinal Fluid of Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01556217 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

Phase: N/A Priority: Normal
NCT ID: NCT00676702 Org: User:
Start: 07/31/08 End: 01/31/09 Due: 01/31/10

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT01932333 Org: User:
Start: 05/31/10 End: 08/31/10 Due: 08/31/11

An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01116206 Org: User:
Start: 05/31/10 End: 03/31/11 Due: 03/31/12

A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT00270062 Org: User:
Start: 05/31/89 End: 07/31/91 Due: 07/31/92

Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00077714 Org: User:
Start: 01/31/04 End: 01/31/05 Due: 01/31/06

A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection

Phase: N/A Priority: Normal
NCT ID: NCT00210639 Org: User:
Start: 08/31/02 End: 05/31/10 Due: 05/31/11

Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00397033 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00050154 Org: User:
Start: 07/31/02 End: 05/31/06 Due: 05/31/07

A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01381887 Org: User:
Start: 06/30/11 End: 11/30/11 Due: 11/30/12

A Pharmacokinetic and Bioavailability Study of 28431754 (Canagliflozin) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01157000 Org: User:
Start: 05/31/10 End: 06/30/10 Due: 06/30/11

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00871507 Org: User:
Start: 04/30/09 End: 07/31/09 Due: 07/31/10

An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks

Phase: N/A Priority: Normal
NCT ID: NCT00338416 Org: User:
Start: 03/31/03 End: 01/31/05 Due: 01/31/06

Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01756404 Org: User:
Start: 06/14/07 End: 12/05/07 Due: 12/05/08

A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone

Phase: N/A Priority: Normal
NCT ID: NCT00838669 Org: User:
Start: 08/31/05 End: 12/31/05 Due: 12/31/06

A Study to Evaluate the Relative Bioavailability, Food Effect and Effect of Ketoconazole on the Rate and Extent of Absorption of Solid Dosage Formulation(s) of JNJ-40411813

Phase: N/A Priority: Normal
NCT ID: NCT01932320 Org: User:
Start: 02/28/10 End: 05/31/10 Due: 05/31/11